Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.22 USD | -0.82% | -4.58% | -13.80% |
05-03 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
05-02 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |